摘要
作者用多抗甲素口服液10mg一日二次,共三月,治疗44例慢性表面抗原携带者,初步证明具有改善HBV血清学标记的近期效果,其中HBeAg、HBVDNA、抗-HBcIgM、抗-HBc、HBsAg及PHSA的阴转率分别为22.72％、15.78％、14.7％、11.36％、11.36％及10％,抗-HBe阴转率为13.6％。对多数患者有改善临床症状作用,对出血倾向具明显改善疗效,且有升高白细胞和血小板的作用。副作用少。
44 Patients of chronic HBsAg carriers were treated with oral polyactin A at the dose of 10mg 2 times daily for 3 months. The results showed that the seroconversion rate from positive to negative for HBeAg was 22.7%, HBV DNA 15.75%, Anti-HBc IgM 14.7%, HBsAg 11.36%, Anti-HBc11.36% and for PHSA was l0%. The seroconversion rat es from negative to positive for Anti-HBe was 13.6%. Among the 44 Anti-HBs negative groups, No one converted to positive. It was shown that the clinical symptoms were much improvedNo. adverse ef-fect occurred.
出处
《华西医讯》
CAS
北大核心
1990年第3期280-282,共3页
